What is it about?
This paper explores whether changes in or access to nicotine/tobacco products can affect psychological symptoms. Specifically, this study examines how reducing nicotine content in cigarettes, along with providing participants access to e-cigarettes, impacts symptoms of depression and anxiety.
Featured Image
Photo by Elsa Olofsson on Unsplash
Why is it important?
As the tobacco market continues to evolve, it will be necessary to monitor the impact of regulatory policies on various outcomes, including psychological symptoms. Our findings suggest that reducing nicotine content in cigarettes may slightly increase symptoms of depression and anxiety; however, providing access to e-cigarettes alongside reduced-nicotine-content cigarettes may help alleviate these symptoms.
Read the Original
This page is a summary of: Effects of very low nicotine content cigarettes and concurrent provision of e-cigarettes on symptoms of depression and anxiety., Experimental and Clinical Psychopharmacology, September 2025, American Psychological Association (APA),
DOI: 10.1037/pha0000803.
You can read the full text:
Contributors
The following have contributed to this page
